Accendra Health
225 hedge funds and large institutions have $1.85B invested in Accendra Health in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 79 increasing their positions, 78 reducing their positions, and 51 closing their positions.
29% more call options, than puts
Call options by funds: $6.05M | Put options by funds: $4.68M
1% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 78
2.07% less ownership
Funds ownership: 102.88% → 100.81% (-2.1%)
10% less funds holding
Funds holding: 249 → 225 (-24)
25% less capital invested
Capital invested by funds: $2.47B → $1.85B (-$618M)
41% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 51
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$18.7M |
| 2 |
Janus Henderson Group
London,
|
+$15.4M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$9.53M |
| 4 |
Man Group
London,
United Kingdom
|
+$6.43M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$17.9M |
| 2 |
D.E. Shaw & Co
New York
|
-$13.4M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$12.9M |
| 4 |
JP Morgan Chase
New York
|
-$9.5M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.33M |
ACH Hedge Fund Activity: Q3 2022 in Review
225 of the 5,830 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q3 2022, worth a combined $1.85B — down 25% from $2.47B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of ACH and 30 opened new positions — a net loss of 21 holders — while 78 trimmed existing stakes and 79 added.
The largest buyer was Boston Partners, opening a new position worth an estimated $18.7M. The largest seller was Eagle Asset Management, cutting an estimated $17.9M.
- 225 institutional investors held Accendra Health (ACH) as of Q3 2022, down from 249 in Q2 2022.
- Funds reported $1.85B of Accendra Health stock for Q3 2022, down 25% quarter-over-quarter.
- 30 funds opened new Accendra Health positions in Q3 2022 and 51 closed out, a net change of -21 holders.
- The largest Accendra Health buyer in Q3 2022 was Boston Partners, an estimated $18.7M added.
- The largest Accendra Health seller in Q3 2022 was Eagle Asset Management, an estimated $17.9M sold.
Based on aggregated 13F filings for Q3 2022.